Efficacy and safety of arterial FOLFOX chemotherapy plus anti-PD-(L)1 immunotherapy as a first-line treatment for unresectable intrahepatic cholangiocarcinoma: a propensity score matching analysis
动脉FOLFOX化疗联合抗PD-(L)1免疫疗法一线治疗不可切除肝内胆管癌的疗效和安全性:倾向评分匹配分析
期刊:Journal of Gastrointestinal Oncology
影响因子:2
doi:10.21037/jgo-24-552
Hu, Yue; Jiang, Xiong-Ying; Cai, Xi; Chen, Song; Chen, Qi-Feng; Yi, Jun-Zhe; Zhong, Sui-Xing; Wang, Jiong-Liang; Xu, Jie; Tan, Gen-Jun; Lyu, Ning; Zhao, Ming